Total NT-proBNP, a novel biomarker in atrial fibrillation. A mechanistic analysis of the GISSI-AF trial
Lidia Staszewsky, Jennifer Meessen, Deborah Novelli, Ulla Wienhues-Thelen, Marcello Disertori, Aldo P Maggioni, Serge Masson, Gianni Tognoni, Maria Grazia Franzosi, Donata Lucci, Roberto Latini, GISSI-AF Investigators.
doi: https://doi.org/10.1101/2020.11.10.20222349
Lidia Staszewsky
1Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
Jennifer Meessen
1Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
Deborah Novelli
1Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
Ulla Wienhues-Thelen
2Roche Diagnostics GmbH, Penzberg, Germany
Marcello Disertori
3Healthcare Research and Innovation Program, IRCS-HTA, BK Foundation, Trento, Italy
Aldo P Maggioni
4ANMCO Research Center, Florence, Italy
Serge Masson
1Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
Gianni Tognoni
1Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
Maria Grazia Franzosi
1Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
Donata Lucci
4ANMCO Research Center, Florence, Italy
Roberto Latini
1Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
Posted November 13, 2020.
Total NT-proBNP, a novel biomarker in atrial fibrillation. A mechanistic analysis of the GISSI-AF trial
Lidia Staszewsky, Jennifer Meessen, Deborah Novelli, Ulla Wienhues-Thelen, Marcello Disertori, Aldo P Maggioni, Serge Masson, Gianni Tognoni, Maria Grazia Franzosi, Donata Lucci, Roberto Latini, GISSI-AF Investigators.
medRxiv 2020.11.10.20222349; doi: https://doi.org/10.1101/2020.11.10.20222349
Total NT-proBNP, a novel biomarker in atrial fibrillation. A mechanistic analysis of the GISSI-AF trial
Lidia Staszewsky, Jennifer Meessen, Deborah Novelli, Ulla Wienhues-Thelen, Marcello Disertori, Aldo P Maggioni, Serge Masson, Gianni Tognoni, Maria Grazia Franzosi, Donata Lucci, Roberto Latini, GISSI-AF Investigators.
medRxiv 2020.11.10.20222349; doi: https://doi.org/10.1101/2020.11.10.20222349
Subject Area
Subject Areas
- Addiction Medicine (313)
- Allergy and Immunology (616)
- Anesthesia (158)
- Cardiovascular Medicine (2253)
- Dermatology (199)
- Emergency Medicine (368)
- Epidemiology (11542)
- Forensic Medicine (10)
- Gastroenterology (676)
- Genetic and Genomic Medicine (3539)
- Geriatric Medicine (336)
- Health Economics (611)
- Health Informatics (2283)
- Health Policy (909)
- Hematology (333)
- HIV/AIDS (741)
- Medical Education (357)
- Medical Ethics (100)
- Nephrology (385)
- Neurology (3322)
- Nursing (189)
- Nutrition (504)
- Oncology (1747)
- Ophthalmology (521)
- Orthopedics (208)
- Otolaryngology (283)
- Pain Medicine (221)
- Palliative Medicine (66)
- Pathology (434)
- Pediatrics (997)
- Primary Care Research (398)
- Public and Global Health (5966)
- Radiology and Imaging (1213)
- Respiratory Medicine (806)
- Rheumatology (367)
- Sports Medicine (309)
- Surgery (383)
- Toxicology (50)
- Transplantation (169)
- Urology (142)